Loading contract…
BETAThis is a new independent transparency project, not an official government website. The data is sourced from public registers and may contain errors, so always verify against the official source. If you find a problem, please report it here.
One or more suppliers on this contract have also made political donations. See supplier details below.
Offer reference number: CM/PHR/20/5600
CM/PHR/20/5600/01 - NHS Framework for the North of England, Branded Medicines -Tranche B - 1 March 2022 to 29 February 2024 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months
CM/PHR/20/5600/02 - NHS Framework for the North of England, Branded Medicines - Annual Tranche Products. Period of framework: 1 March 2022 to 28 February 2023 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 12 months.
CM/PHR/20/5600/03- NHS Framework for Insulin Aspart Biosimilar (Trurapi®), South of England - Period of framework: 1 March 2022 to 31 August 2022 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 12 months.
CM/PHR/20/5600/04 - NHS Framework for Insulin Aspart Biosimilar (Trurapi®), London - Period of framework: 1 March 2022 to 31 August 2023 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months.
CM/PHR/20/5600/05 - NHS Framework for Insulin Aspart Biosimilar (Trurapi®), Midlands and East - Period of framework: 1 March 2022 to 28 February 2023 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months.
| Supplier | Identifier | Award Value | Cross-References |
|---|---|---|---|
| Accord-UK Ltd | 00079585 | ~£716,741,676 estimated from lot values | - |
| Amgen Ltd | 02354269 | ~£716,741,676 estimated from lot values | - |
| AstraZeneca | 03674842 | ~£716,741,676 estimated from lot values | LOBBYIST Incisive Health Ltd (6 quarters) FTI Consulting LLP (6 quarters) Teneo Strategy Limited (3 quarters) Hanover Communications International Limited (2 quarters) MHP Communications (1 quarter) |
| Aventis Pharma ltd t/a Sanofi | 01535640 | ~£716,741,676 estimated from lot values | DONOR£101K across 3 donations To: Pauline Latham MP, Derek Thomas, Labour Party |
| Bayer Ltd | 16954143 | ~£716,741,676 estimated from lot values | - |
| Biogen | 06151086 | ~£716,741,676 estimated from lot values | - |
| Bristol Myers Squibb | 02487574 | ~£716,741,676 estimated from lot values | - |
| Celltrion Healthcare United Kingdom Limited | 11685363 | ~£716,741,676 estimated from lot values | - |
| CST Pharma Limited | 04212740 | ~£716,741,676 estimated from lot values | - |
| Eli Lilly & Company Ltd | 00284385 | ~£716,741,676 estimated from lot values | DONOR£9K across 1 donation To: Conservative and Unionist Party |
| Gedeon Richter UK Ltd | 04325685 | ~£716,741,676 estimated from lot values | - |
| Gilead Sciences Limited | 02543818 | ~£716,741,676 estimated from lot values | LOBBYIST Ovid Consulting Ltd (4 quarters) WA Communications Ltd (1 quarter) Portland PR Limited (1 quarter) |
| GlaxoSmithKline UK Limited | 04310159 | ~£716,741,676 estimated from lot values | LOBBYIST Hill & Knowlton Limited (4 quarters) Global Counsel Ltd (1 quarter) |
| Ipsen | 06751069 | ~£716,741,676 estimated from lot values | LOBBYIST Burkitt Communications Ltd (2 quarters) WA Communications Ltd (1 quarter) |
| Janssen-Cilag Ltd | 01027904 | ~£716,741,676 estimated from lot values | LOBBYIST Ovid Consulting Ltd (4 quarters) |
| Merck Serono Limited | 00990823 | ~£716,741,676 estimated from lot values | MP LINK Munira Wilson— Employment and earnings |
| Merck Sharpe & Dohme (UK) Limited | - | ~£716,741,676 estimated from lot values | - |
| Mylan | 05460854 | ~£716,741,676 estimated from lot values | - |
| Napp Pharmaceuticals Ltd | 03690299 | ~£716,741,676 estimated from lot values | - |
| Novo Nordisk | 01118740 | ~£716,741,676 estimated from lot values | LOBBYIST WA Communications Ltd (7 quarters) Hanover Communications International Limited (2 quarters) MHP Communications (1 quarter) |
| Organon Pharmaceuticals UK Ltd | - | ~£716,741,676 estimated from lot values | - |
| Pfizer Ltd | 00526209 | ~£716,741,676 estimated from lot values | DONOR£41K across 4 donations To: Progressive Britain Ltd (formally Progress Ltd) LOBBYIST Portland PR Limited (20 quarters) Ovid Consulting Ltd (3 quarters) Hanover Communications International Limited (3 quarters) MHP Communications (1 quarter) Incisive Health Ltd (1 quarter) FORMER MP John Austin— Gifts, benefits and hospitality from UK sources (former) |
| Roche Products Ltd | 00100674 | ~£716,741,676 estimated from lot values | LOBBYIST M&F Health (5 quarters) Ovid Consulting Ltd (2 quarters) |
| Sandoz Ltd | 01547204 | ~£716,741,676 estimated from lot values | - |
| Sobi (Swedish Orphan Biovitrum Ltd) | - | ~£716,741,676 estimated from lot values | - |
| Takeda UK Ltd | 03362860 | ~£716,741,676 estimated from lot values | LOBBYIST Hill & Knowlton Limited (3 quarters) MHP Communications (2 quarters) Hanover Communications International Limited (2 quarters) Burkitt Communications Ltd (1 quarter) Incisive Health Ltd (1 quarter) FORMER MP Sir Kevin Barron— Employment and earnings (former) |
| Teva UK Limited | 00302461 | ~£716,741,676 estimated from lot values | - |
| Thornton and Ross Ltd | 00185947 | ~£716,741,676 estimated from lot values | - |
| UCB Pharma Ltd | 00209905 | ~£716,741,676 estimated from lot values | - |
| UL Global Pharma | - | ~£716,741,676 estimated from lot values | - |
| Zentiva Pharma UK Ltd | 02158996 | ~£716,741,676 estimated from lot values | - |
Government spending data: These suppliers have received £1,217,629,810 in 6,275 payments (over £25k) from UK Health Security Agency, Department of Health and Social Care, Manchester University NHS Foundation Trust, NHS England, Royal Cornwall Hospitals NHS Trust and 21 more public bodies (2010-04-28 to 2026-03-31).